Evidence map›Paper›PMID 38850666›Full record

ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2024

Cannabinoid CB

Kelsey G Guenther, Xiaoyan Lin, Zhili Xu, Alexandros Makriyannis, Julian Romero, Cecilia J Hillard, Ken Mackie, Andrea G Hohmann

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Cannabinoid CBBritish journal of pharmacology · 2025
    Review
  5. Article
  6. The cannabinoid CBNeuropharmacology · 2025
    Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Kelsey G GuentherProgram in Neuroscience, Indiana University, Bloomington, IN, United States; Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States.
Xiaoyan LinProgram in Neuroscience, Indiana University, Bloomington, IN, United States; Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States.
Zhili XuProgram in Neuroscience, Indiana University, Bloomington, IN, United States; Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States.
Alexandros MakriyannisCenter for Drug Discovery, Northeastern University, Boston, MA, United States.
Julian RomeroFaculty of Experimental Sciences, Universidad Francisco de Vitoria, 28223 Pozuelo de Alarcón, Madrid, Spain.
Cecilia J HillardDepartment of Pharmacology and Toxicology, Med. Col. Of Wisconsin, Milwaukee, WI, United States.
Ken MackieProgram in Neuroscience, Indiana University, Bloomington, IN, United States; Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States; Gill Center for Biomolecular Science, Indiana University, Bloomington, IN, United States.
Andrea G HohmannProgram in Neuroscience, Indiana University, Bloomington, IN, United States; Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States; Gill Center for Biomolecular Science, Indiana University, Bloomington, IN, United States. Electronic address: hohmanna@indiana.edu.

Funding

Project 3 - In vivo pharmacology of cannabinoid receptor probesP01DA009158 · NIDA · UNIVERSITY OF CONNECTICUT STORRS · PI Alexandros Makriyannis · 1994 to 2026
$26.0M
CB2 Cannabinoid Mechanisms for Suppressing Opioid Tolerance and DependenceR01DA047858 · NIDA · TRUSTEES OF INDIANA UNIVERSITY · PI HOHMANN, ANDREA GRACE, MACKIE, KENNETH · 2019 to 2023
$2.6M
NIDA NIH HHS P01 DA009158NIDA NIH HHS R01 DA047858
6 · The paper itself

Abstract

Cannabinoid CB

Indexed as

Drug ToleranceMorphineNeuralgiaPaclitaxelReceptor, Cannabinoid, CB2Sensory Receptor CellsAnimalsCannabinoid Receptor AgonistsFemaleMaleMiceMice, Inbred C57BLMice, KnockoutNociceptionSex CharacteristicsCannabinoid Receptor AgonistsMorphinePaclitaxelReceptor, Cannabinoid, CB2CancerCB2Chemotherapy-induced peripheral neuropathyDorsal root ganglionOpioid tolerance

Identifiers

PMID38850666
PMCPMC11209786

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.